ZIOPHARM Oncology (NASDAQ:ZIOP) Upgraded to “Buy” by Zacks Investment Research – Riverton Roll
ZIOPHARM Oncology (NASDAQ:ZIOP) Upgraded to “Buy” by Zacks Investment Research Riverton Roll
Source: Investment New Feed
ZIOPHARM Oncology (NASDAQ:ZIOP) Upgraded to “Buy” by Zacks Investment Research Riverton Roll
Source: Investment New Feed